Non-Invasive Measurement of Pulmonary Dysfunction in Children with Cerebral Palsy

脑瘫儿童肺功能障碍的无创测量

• 批准号: 10646934
• 负责人: TARIQ RAHMAN
• 金额: $ 22.54万
• 依托单位: ALFRED I. DU PONT HOSP FOR CHILDREN
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-04-15 至 2025-03-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10646934
• 关键词: Abdomen; Accident and Emergency department; Address; Adult; Biomedical Engineering; Breathing; Cerebral Palsy; Chest; Child; Childhood; Classification; Clinic; Clinical Research; Coughing; Data; Diagnosis; Diagnostic; Effectiveness; Ensure; Failure; Flowmeters; Functional disorder; Gait; Goals; Image; Incidence; Institution; Intensive Care; Laboratories; Link; Live Birth; Lung; Lung diseases; Managed Care; Measurement; Measures; Mechanics; Methodology; Motor; Mucous body substance; Operating Rooms; Outcome; Patients; Persons; Phase; Plethysmography; Pneumonia; Qualifying; Research; Research Personnel; Respiratory Diaphragm; Respiratory Insufficiency; Respiratory Muscles; Respiratory distress; Respiratory physiology; Risk; Scientist; Screening procedure; Severities; Sleep; Spirometry; Stress; Symptoms; System; Techniques; Technology; Testing; Time; Visual; Walking; Wheelchairs; Work of Breathing; awake; cohort; disability; experience; indexing; innovation; neuromuscular; novel; pulmonary function; respiratory; rib bone structure; scoliosis; screening; sensor; standard measure; wireless transmission

Project Summary This R21 application proposes the utilization of a novel non-invasive real-time breathing sensor – pneuRIP- to measure pulmonary function (PF) in children with high-level cerebral palsy. Currently the standard measures of PF such as spirometry and peak flow meters are too strenuous for children and those with severe CP, as a result they have low compliance rates. The pneuRIP does not require active user participation and can passively measure PF. It consists of two inductive bands worn around the chest and abdomen that measure and differentiate diaphragmatic and chest breathing through Respiratory Inductance Plethysmography (RIP). Readings are recorded and analyzed on a small chest-worn unit and wirelessly transmitted to an iPad. The pneuRIP yields indices of work of breathing (WOB) which includes the phase angle between the chest and abdomen; percentage breathing through the ribcage; respiratory rate; and labored breathing index. This sensor takes little time to set up and readings are provided instantaneously. The WOB indices provide a screening tool for pulmonary diagnosis and treatment, decrease the risk for pneumonia and respiratory illness, and has the potential to act as a marker for scoliosis in children with high- level CP. Our research team (clinicians, basic scientists, bioengineers & therapists) has shown the effectiveness of the proposed PF methodology in both intensive care, emergency departments, operating rooms, and neuromuscular clinics. The impact on the field will be to have a simple and fast way to measure pulmonary function in children and adults with severe CP and correlate this to measures of function and scoliosis severity as the effects of scoliosis, which is common in CP, on pulmonary function is unclear. Measures of motor function are classified by the Gross Motor Functional Classification System (GMFCS), ranking from I to V, with worsening disability from near normal gait in Type I to complete wheelchair use in Type V. This project will address GMFCS levels IV and V which includes people using wheelchairs. The two specific aims are a) Measure WOB indices non- invasively using the pneuRIP sensor in children with CP who use a wheelchair (GMFCS level IV, V) and validate the use of WOB indices as a screening test for pulmonary dysfunction., 2) Determine the correlation between WOB indices and the degree of scoliosis using the pneuRIP sensor in 250 children with CP who use a wheelchair (GMFCS level IV, V). The proposed research is innovative because this RIP technology to date has not been incorporated in the diagnosis and treatment of children with CP. The advantages include provision of the diagnostic data in real-time, less stress to the patients, and a reduction in lab testing and imaging. Collectively, we expect the outcomes of these clinical studies will greatly add to pulmonary treatment in CP.

项目总结